These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8820482)

  • 1. Comparison of an antibody model with an X-ray structure: the variable fragment of BR96.
    Bajorath J; Sheriff S
    Proteins; 1996 Feb; 24(2):152-7. PubMed ID: 8820482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling.
    Eigenbrot C; Randal M; Presta L; Carter P; Kossiakoff AA
    J Mol Biol; 1993 Feb; 229(4):969-95. PubMed ID: 8095303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-ray structure of the uncomplexed anti-tumor antibody BR96 and comparison with its antigen-bound form.
    Sheriff S; Chang CY; Jeffrey PD; Bajorath J
    J Mol Biol; 1996 Jun; 259(5):938-46. PubMed ID: 8683596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of BR96 binding sites for antigen and anti-idiotype by codon-based scanning mutagenesis.
    Rosok MJ; Eghtedarzadeh-Kondri M; Young K; Bajorath J; Glaser S; Yelton D
    J Immunol; 1998 Mar; 160(5):2353-9. PubMed ID: 9498776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canonical antigen-binding loop structures in immunoglobulins: more structures, more canonical classes?
    Decanniere K; Muyldermans S; Wyns L
    J Mol Biol; 2000 Jun; 300(1):83-91. PubMed ID: 10864500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular recognition of a peptide mimic of the Lewis Y antigen by an anti-Lewis Y antibody.
    Murali R; Kieber-Emmons T
    J Mol Recognit; 1997; 10(6):269-76. PubMed ID: 9770651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
    Paula S; Monson N; Ball WJ
    Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The x-ray structure of an anti-tumour antibody in complex with antigen.
    Jeffrey PD; Bajorath J; Chang CY; Yelton D; Hellström I; Hellström KE; Sheriff S
    Nat Struct Biol; 1995 Jun; 2(6):466-71. PubMed ID: 7664109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational analysis of the first observed non-proline cis-peptide bond occurring within the complementarity determining region (CDR) of an antibody.
    Bates PA; Dokurno P; Freemont PS; Sternberg MJ
    J Mol Biol; 1998 Dec; 284(3):549-55. PubMed ID: 9826497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced conformational diversity search of CDR-H3 in antibodies: role of the first CDR-H3 residue.
    Kim ST; Shirai H; Nakajima N; Higo J; Nakamura H
    Proteins; 1999 Dec; 37(4):683-96. PubMed ID: 10651282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational sampling of CDR-H3 in antibodies by multicanonical molecular dynamics simulation.
    Shirai H; Nakajima N; Higo J; Kidera A; Nakamura H
    J Mol Biol; 1998 May; 278(2):481-96. PubMed ID: 9571065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the disulfide-stabilized Fv fragment of anticancer antibody B1: conformational influence of an engineered disulfide bond.
    Almog O; Benhar I; Vasmatzis G; Tordova M; Lee B; Pastan I; Gilliland GL
    Proteins; 1998 May; 31(2):128-38. PubMed ID: 9593187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The third-dimensional structure of the complex between an Fv antibody fragment and an analogue of the main immunogenic region of the acetylcholine receptor: a combined two-dimensional NMR, homology, and molecular modeling approach.
    Kleinjung J; Petit MC; Orlewski P; Mamalaki A; Tzartos SJ; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Marraud M; Cung MT
    Biopolymers; 2000 Feb; 53(2):113-28. PubMed ID: 10679615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The variable domain glycosylation in a monoclonal antibody specific to GnRH modulates antigen binding.
    Khurana S; Raghunathan V; Salunke DM
    Biochem Biophys Res Commun; 1997 May; 234(2):465-9. PubMed ID: 9177294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refined structure of an intact IgG2a monoclonal antibody.
    Harris LJ; Larson SB; Hasel KW; McPherson A
    Biochemistry; 1997 Feb; 36(7):1581-97. PubMed ID: 9048542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
    Fan ZC; Shan L; Goldsteen BZ; Guddat LW; Thakur A; Landolfi NF; Co MS; Vasquez M; Queen C; Ramsland PA; Edmundson AB
    J Mol Recognit; 1999; 12(1):19-32. PubMed ID: 10398393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting antibody complementarity determining region structures without classification.
    Choi Y; Deane CM
    Mol Biosyst; 2011 Dec; 7(12):3327-34. PubMed ID: 22011953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformations of the third hypervariable region in the VH domain of immunoglobulins.
    Morea V; Tramontano A; Rustici M; Chothia C; Lesk AM
    J Mol Biol; 1998 Jan; 275(2):269-94. PubMed ID: 9466909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional model of the BR96 monoclonal antibody variable fragment.
    Bajorath J
    Bioconjug Chem; 1994; 5(3):213-9. PubMed ID: 7522581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution.
    Mylvaganam SE; Paterson Y; Getzoff ED
    J Mol Biol; 1998 Aug; 281(2):301-22. PubMed ID: 9698550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.